DCM Shriram has achieved complete operational status for its epichlorohydrin manufacturing facility at Jhagadia with the commissioning of the final capacity phase. The company announced through a regulatory disclosure that the remaining 17,000 TPA capacity was commissioned on April 1, 2026, at 4:00 pm, completing the full 52,000 TPA plant capacity.

Plant Commissioning Timeline

The epichlorohydrin plant was commissioned in two phases, demonstrating the company's phased expansion approach:

Facility Specifications

The fully operational facility represents a significant addition to DCM Shriram's chemical manufacturing capabilities:

Strategic Impact

The completion of the epichlorohydrin plant strengthens DCM Shriram's position in the specialty chemicals sector. Epichlorohydrin serves as a crucial industrial chemical for manufacturing epoxy resins, synthetic glycerin, and various specialty chemical products. The facility's strategic location at the Jhagadia chemical complex provides operational advantages for raw material sourcing and product distribution.

The phased commissioning approach allowed the company to optimize operations and ensure smooth scaling of production capacity. With the plant now fully operational at 52,000 TPA, DCM Shriram is positioned to serve growing market demand for epichlorohydrin and related chemical products.

DCM Shriram has received a significant update in its ongoing tax litigation for Assessment Year 2021-22, with the Income-tax Appellate Tribunal (ITAT), New Delhi delivering a favorable order on March 18, 2026. The company disclosed this development under Regulation 30 of SEBI listing regulations, noting that it became aware of the order on March 18, 2026, at around 6:15 PM.

ITAT Order Details

The tribunal's adjudication on the order under section 143(3) read with section 144C(13) resulted in substantial relief for the company. The detailed breakdown of the ITAT's decision is presented below:

The company has explicitly stated that this development has no material impact on its profit and loss statement, providing reassurance to stakeholders about the financial implications.

Previous Litigation Context

This latest order addresses part of DCM Shriram's broader tax litigation challenges. The company referenced previous unwarranted additions made under section 143(1) dated October 25, 2022, which amounted to Rs. 238.02 crores with a tax effect of Rs. 83.17 crores. These matters were previously adjudicated through ITAT's order dated July 30, 2025, and were referred to the Assessing Officer for de novo adjudication in accordance with law, with the company receiving this information on August 11, 2025.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This update follows the company's earlier communications dated October 26, 2024, and August 12, 2025, regarding the same material tax litigation proceedings before ITAT Delhi.

Current Status

With the ITAT granting substantial relief of Rs. 9.79 crores out of the total tax effect of Rs. 12.20 crores, DCM Shriram has achieved a favorable outcome in this phase of litigation. The remaining Rs. 2.41 crores has been referred back to the Assessing Officer for further consideration, indicating that while significant relief has been obtained, some matters require additional review at the assessment level.